CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Altered transcriptional and translational levels of Nm23H1 in north Indian breast cancer females and it’s prognostic relevance

Author: 
Richa Singh, Madan Lal Brahma Bhatt, Saurabh Pratap Singh, Vijay Kumar, Madhu Mati Goel, Durga Prasad Mishra and Rajendra Kumar
Subject Area: 
Health Sciences
Abstract: 

Background: Breast cancer is the commonest female cancer worldwide and metastasis deteriorates it’s therapeutic outcome. Several clinicopathological parameters have been associated with metastatic suppressor gene (MSG) expression levels that decipher it’s prognostic/predictive significance. The role of MSG Nm23H1 in breast cancer is inconclusive. Our goal was to investigate the possible clinical significance and correlation of Nm23H1 with metastatic breast cancer. Materials & methods: The study was conducted on 178 histologically proven cases of breast cancer and similar number of matched controls. Semi quantitative reverse transcriptase polymerase chain reaction (RT PCR) and immunohistochemistry (IHC) were used to investigate KiSS1 at gene and protein level, respectively. The Nm23H1 levels were correlated with several patient characteristics including age, family history, hormonal receptor status, stage, tumor size, nodal involvement and metastatic manifestation. Statistical analysis was done to evaluate correlation between expression of Nm23H1 and clinicopathological parameters. Results: Our study revealed (i) Diminished Nm23H1 levels in normal vs breast cancer (p < 0.05). (ii) Likewise, a statistically significant down-regulation of NM23H1 was observed in metastatic cases vs non metastatic in breast cancer (P = 0.04). (iii) NM23H1 levels strongly correlated with T,N,M category, histological grade and advanced stage (p<0.001) and not associated with any other studied parameter. Conclusion: Conclusively, reduced Nm23H1 expression is a negative prognostic factor for OS, advancing tumor stage, axillary lymph node status, metastatic propensity and advancing grade of the breast cancer patient. Patients with negative Nm23H1 expression may require a more intensive therapeutic strategy.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran